Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SNOA Stock Summary
Top 10 Correlated ETFs
SNOA
In the News

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product
Sonoma Pharmaceuticals shares jumped 44% on Friday after the company unveiled a product that could replace IV bags for some surgeries.

Markets End the Week in the Green in Anticipation the Fed Will Pause Rate Hikes
Markets posted a winning day on Friday, June 9, 2023, to top off a winning week on optimism the Fed may pause its interest rate hike cycle next week.

5 Penny Stocks To Watch With Big News This Week
Penny stocks to watch with news. The post 5 Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

7 Top Penny Stocks To Watch With Big News This Week
Penny Stocks With News Light Up The Scanners This Week This week

Why Investing in Penny Stocks Could Be Worth It
Are penny stocks worth investing in? The post Why Investing in Penny Stocks Could Be Worth It appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?
Sonoma Pharmaceuticals (NASDAQ: SNOA ) stock is rocketing higher on Wednesday following positive news for its Microcyn Rx products. The big news here is Sonoma Pharmaceuticals getting a Distribution and Pricing Agreement (DAPA) from the Defense Logistics Agency ( DLA ).

What Makes Penny Stocks an Attractive Investment?
Are penny stocks on your watchlist right now? The post What Makes Penny Stocks an Attractive Investment?

Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?
Sonoma Pharmaceuticals (SNOA) stock is getting a boost on Tuesday after the company revealed positive disinfectant news from the EPA. The post Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?

Best Penny Stocks to Buy Today? 3 to Watch on May 3rd
What to know about buying penny stocks on May 3rd The post Best Penny Stocks to Buy Today? 3 to Watch on May 3rd appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
SNOA Financial details
SNOA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 20.53 | 12.82 | 9.33 | 4.76 | 3.91 | |
Net income per share | -12.77 | -1.99 | -2.31 | -1.92 | -1.52 | |
Operating cash flow per share | -12.68 | -3.11 | -1.69 | -1.6 | -1.81 | |
Free cash flow per share | -12.79 | -3.25 | -1.78 | -1.65 | -1.89 | |
Cash per share | 3.99 | 2.5 | 2.11 | 2.79 | 1.13 | |
Book value per share | 11.35 | 5.89 | 2.69 | 3.28 | 2.35 | |
Tangible book value per share | 11.35 | 5.89 | 2.69 | 3.28 | 2.35 | |
Share holders equity per share | 11.35 | 5.89 | 2.69 | 3.28 | 2.35 | |
Interest debt per share | 0.55 | 1.01 | 1.35 | 0.51 | 0.25 | |
Market cap | 7.65M | 7.24M | 14.83M | 10.64M | 3.33M | |
Enterprise value | 4.44M | 5.02M | 13.29M | 4.61M | 355.12K | |
P/E ratio | -0.65 | -2.46 | -3.21 | -2.09 | -0.65 | |
Price to sales ratio | 0.4 | 0.38 | 0.8 | 0.84 | 0.25 | |
POCF ratio | -0.65 | -1.58 | -4.39 | -2.5 | -0.54 | |
PFCF ratio | -0.65 | -1.51 | -4.17 | -2.43 | -0.52 | |
P/B Ratio | 0.73 | 0.83 | 2.77 | 1.22 | 0.42 | |
PTB ratio | 0.73 | 0.83 | 2.77 | 1.22 | 0.42 | |
EV to sales | 0.23 | 0.27 | 0.71 | 0.37 | 0.03 | |
Enterprise value over EBITDA | -0.41 | -0.83 | -3.5 | -0.7 | -0.08 | |
EV to operating cash flow | -0.38 | -1.09 | -3.93 | -1.09 | -0.06 | |
EV to free cash flow | -0.38 | -1.05 | -3.73 | -1.05 | -0.06 | |
Earnings yield | -1.54 | -0.41 | -0.31 | -0.48 | -1.55 | |
Free cash flow yield | -1.54 | -0.66 | -0.24 | -0.41 | -1.93 | |
Debt to equity | 0.05 | 0.17 | 0.5 | 0.16 | 0.11 | |
Debt to assets | 0.03 | 0.1 | 0.18 | 0.07 | 0.05 | |
Net debt to EBITDA | 0.3 | 0.36 | 0.41 | 0.92 | 0.67 | |
Current ratio | 3.48 | 2.55 | 3.18 | 2.82 | 3.71 | |
Interest coverage | -341.15 | -416.94 | -287.42 | 588.7 | -285.63 | |
Income quality | 0.99 | 1.56 | 0.86 | 0.84 | 1.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.98 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.07 | 0.03 | 0.01 | 0.02 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.04 | 0.05 | 0.03 | 0.04 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -0.22 | -0.66 | -0.79 | -0.74 | -2.15 | |
Stock based compensation to revenue | 0.09 | 0.04 | 0.02 | 0.03 | 0.05 | |
Graham number | 57.11 | 16.26 | 11.82 | 11.89 | 8.96 | |
ROIC | -1.05 | -0.62 | -0.46 | -0.52 | -0.49 | |
Return on tangible assets | -0.82 | -0.2 | -0.31 | -0.27 | -0.32 | |
Graham Net | 5.16 | 2 | -0.32 | 0.82 | 0.53 | |
Working capital | 8.91M | 7.52M | 8.91M | 10.61M | 10.08M | |
Tangible asset value | 10.49M | 8.71M | 5.36M | 8.7M | 7.98M | |
Net current asset value | 8.54M | 6.53M | 3.36M | 6.28M | 5.54M | |
Invested capital | 0.05 | 0.17 | 0.5 | 0.16 | 0.11 | |
Average receivables | 2.99M | 4.91M | 5.01M | 4.72M | 5.6M | |
Average payables | 1.26M | 1.67M | 1.93M | 1.71M | 1.24M | |
Average inventory | 3.14M | 2.8M | 2.36M | 2.6M | 2.76M | |
Days sales outstanding | 85.51 | 103.45 | 91.23 | 138.1 | 176.48 | |
Days payables outstanding | 45.4 | 71.81 | 53.5 | 69.36 | 34.9 | |
Days of inventory on hand | 123.32 | 75.46 | 76.51 | 112.56 | 118.61 | |
Receivables turnover | 4.27 | 3.53 | 4 | 2.64 | 2.07 | |
Payables turnover | 8.04 | 5.08 | 6.82 | 5.26 | 10.46 | |
Inventory turnover | 2.96 | 4.84 | 4.77 | 3.24 | 3.08 | |
ROE | -1.12 | -0.34 | -0.86 | -0.58 | -0.65 | |
Capex per share | -0.11 | -0.14 | -0.09 | -0.05 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 1.28 | 1.07 | 0.95 | 0.89 | 0.69 | |
Net income per share | -0.29 | -0.33 | -0.62 | -0.39 | -0.29 | |
Operating cash flow per share | -0.49 | -0.59 | -0.11 | -0.72 | -0.04 | |
Free cash flow per share | -0.5 | -0.6 | -0.12 | -0.78 | -0.05 | |
Cash per share | 1.8 | 1.08 | 0.85 | 1.13 | 0.72 | |
Book value per share | 2.57 | 2.26 | 1.79 | 2.35 | 1.47 | |
Tangible book value per share | 2.57 | 2.26 | 1.79 | 2.35 | 1.47 | |
Share holders equity per share | 2.57 | 2.26 | 1.79 | 2.35 | 1.47 | |
Interest debt per share | 0.33 | 0.25 | 0.16 | 0.34 | 0.13 | |
Market cap | 9.05M | 6.61M | 3.48M | 3.33M | 5.28M | |
Enterprise value | 4.42M | 4.03M | 1.33M | 355.12K | 2.39M | |
P/E ratio | -2.55 | -1.62 | -0.45 | -0.64 | -0.93 | |
Price to sales ratio | 2.27 | 1.98 | 1.18 | 1.1 | 1.54 | |
POCF ratio | -5.91 | -3.61 | -10 | -1.36 | -24.57 | |
PFCF ratio | -5.82 | -3.56 | -9.18 | -1.26 | -22.77 | |
P/B Ratio | 1.14 | 0.94 | 0.63 | 0.42 | 0.73 | |
PTB ratio | 1.14 | 0.94 | 0.63 | 0.42 | 0.73 | |
EV to sales | 1.11 | 1.21 | 0.45 | 0.12 | 0.7 | |
Enterprise value over EBITDA | -5.37 | -5.73 | -0.74 | -0.32 | -2 | |
EV to operating cash flow | -2.88 | -2.2 | -3.83 | -0.15 | -11.13 | |
EV to free cash flow | -2.84 | -2.17 | -3.51 | -0.13 | -10.31 | |
Earnings yield | -0.1 | -0.15 | -0.56 | -0.39 | -0.27 | |
Free cash flow yield | -0.17 | -0.28 | -0.11 | -0.79 | -0.04 | |
Debt to equity | 0.12 | 0.11 | 0.09 | 0.11 | 0.09 | |
Debt to assets | 0.06 | 0.05 | 0.03 | 0.05 | 0.04 | |
Net debt to EBITDA | 5.62 | 3.67 | 1.19 | 2.67 | 2.42 | |
Current ratio | 3.05 | 3.51 | 2.86 | 3.71 | 3.36 | |
Interest coverage | -12.76 | -243.67 | -1.83K | -3.93 | 0 | |
Income quality | 1.73 | 1.8 | 0.18 | 1.87 | 0.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0.07 | 0.09 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0.01 | 0.09 | 0.08 | 0.08 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.06 | 0 | |
Capex to depreciation | -0.74 | -0.89 | -0.97 | -5.59 | -0.38 | |
Stock based compensation to revenue | 0.05 | 0.03 | 0.08 | 0.03 | 0.05 | |
Graham number | 4.06 | 4.09 | 5.01 | 4.51 | 3.08 | |
ROIC | -0.09 | -0.1 | -0.29 | -0.11 | -0.15 | |
Return on tangible assets | -0.05 | -0.07 | -0.14 | -0.08 | -0.09 | |
Graham Net | -0.13 | -0.39 | -0.83 | 0.53 | -0.39 | |
Working capital | 9.96M | 8.87M | 7.3M | 10.08M | 9.55M | |
Tangible asset value | 7.96M | 7.02M | 5.56M | 7.98M | 7.24M | |
Net current asset value | 5.62M | 4.45M | 2.86M | 5.54M | 4.94M | |
Invested capital | 0.12 | 0.11 | 0.09 | 0.11 | 0.09 | |
Average receivables | 3.61M | 2.46M | 2.39M | 4.36M | 4.43M | |
Average payables | 1.85M | 1.57M | 1.19M | 1.07M | 965.5K | |
Average inventory | 2.73M | 2.91M | 2.94M | 2.85M | 2.79M | |
Days sales outstanding | 55 | 67.2 | 70.22 | 191.62 | 64.05 | |
Days payables outstanding | 72.97 | 48.45 | 55.46 | 35.2 | 44.13 | |
Days of inventory on hand | 98.9 | 136.47 | 121.35 | 119.64 | 110.53 | |
Receivables turnover | 1.64 | 1.34 | 1.28 | 0.47 | 1.41 | |
Payables turnover | 1.23 | 1.86 | 1.62 | 2.56 | 2.04 | |
Inventory turnover | 0.91 | 0.66 | 0.74 | 0.75 | 0.81 | |
ROE | -0.11 | -0.14 | -0.35 | -0.16 | -0.2 | |
Capex per share | -0.01 | -0.01 | -0.01 | -0.06 | 0 |
SNOA Frequently Asked Questions
What is Sonoma Pharmaceuticals, Inc. stock symbol ?
Sonoma Pharmaceuticals, Inc. is a US stock , located in Woodstock of Ga and trading under the symbol SNOA
What is Sonoma Pharmaceuticals, Inc. stock quote today ?
Sonoma Pharmaceuticals, Inc. stock price is $0.777 today.
Is Sonoma Pharmaceuticals, Inc. stock public?
Yes, Sonoma Pharmaceuticals, Inc. is a publicly traded company.